Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors
摘要:
Fluorinated isoflavanones and bifunctionalized isoflavanones were synthesized through a one-step gold(I)-catalyzed annulation reaction. These compounds were evaluated for their in vitro inhibitory activities against aromatase in a fluorescence-based enzymatic assay. Selected compounds were tested for their anti-proliferative effects on human breast cancer cell line MCF-7. Compounds 6-methoxy-3-(pyridin-3-yl)chroman-4-one (3c) and 6-fluoro-3-(pyridin-3-yl)chroman-4-one (3e) were identified as the most potent aromatase inhibitors with IC50 values of 2.5 mu M and 0.8 mu M. Therefore, these compounds have great potential for the development of pharmaceutical agents against breast cancer. (C) 2013 Elsevier Ltd. All rights reserved.
Palladium-Catalyzed Direct Arylation of 4-Chromanones: Selective Synthesis of Racemic Isoflavanones and 3,3-Diaryl-4-chromanones
作者:Fabio Bellina、Tiziana Masini、Renzo Rossi
DOI:10.1002/ejoc.200901356
日期:2010.3
yields and with high selectivity by Pd-catalyzed direct C-3 arylation of 3-unsubstituted 4-chromanones with aryl bromides with the aid of a Pd 2 (dba) 3 /tBu 3 PHBF 4 catalyst system in the presence of KHCO 3 as the base in a dioxane/water mixture (4:1). This catalyst system has also been employed in an unprecedented synthesis of 3,3-diaryl-4-chromanones through directarylation of 4-chromanones in
Investigation of fluorinated and bifunctionalized 3-phenylchroman-4-one (isoflavanone) aromatase inhibitors
作者:Erica Amato、Tony Bankemper、Rebecca Kidney、Thuy Do、Alma Onate、Fathima Shazna Thowfeik、Edward J. Merino、Stefan Paula、Lili Ma
DOI:10.1016/j.bmc.2013.11.045
日期:2014.1
Fluorinated isoflavanones and bifunctionalized isoflavanones were synthesized through a one-step gold(I)-catalyzed annulation reaction. These compounds were evaluated for their in vitro inhibitory activities against aromatase in a fluorescence-based enzymatic assay. Selected compounds were tested for their anti-proliferative effects on human breast cancer cell line MCF-7. Compounds 6-methoxy-3-(pyridin-3-yl)chroman-4-one (3c) and 6-fluoro-3-(pyridin-3-yl)chroman-4-one (3e) were identified as the most potent aromatase inhibitors with IC50 values of 2.5 mu M and 0.8 mu M. Therefore, these compounds have great potential for the development of pharmaceutical agents against breast cancer. (C) 2013 Elsevier Ltd. All rights reserved.